Remove Investors Remove IPO Remove Portfolio
article thumbnail

Eyes on the exit: Selling PE portfolio companies in complex markets

JD Supra: Mergers

By: White & Case LLP

Portfolio 171
article thumbnail

Wall Street loves this recent IPO with one analyst calling it the ‘social network trading platform’

CNBC: Investing

The stock opened that day at $69.69, or 34% above its IPO, and closed up nearly 29% at $67 per share. The overwhelming positive sentiment from Wall Street has rewarded the company's decision to go public after a lengthy dry spell for IPOs. Here's what analysts at some of the biggest shops on Wall Street had to say on the IPO.

IPO 60
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Goldman Sachs says buy these five stocks that are set to rally

CNBC: Investing

The Wall Street firm says these companies are resilient and that investors should quickly buy them. CNBC Pro combed through Goldman Sachs research to find five buy-rated stocks that it says have more upside. They include: Apple, MasTec, BJ's, Valvoline and Kontoor Brands.

Stock 126
article thumbnail

Here are Tuesday's biggest analyst calls: Nvidia, Apple, Tesla, Oracle, Amazon, Netflix, CoreWeave, JPMorgan, & more

CNBC: Investing

"We are upgrading PNC shares from Market Perform to Outperform, increasing our EPS estimates following recent commentary at an investor conference, and establishing a $220 price target." " Raymond James upgrades PNC to outperform from market perform Raymond James says the regional bank is well positioned.

Stock 76
article thumbnail

Finding opportunities in alternative asset managers and a bearish call on the U.S. dollar

CNBC: Investing

Investors are looking for opportunities in alternative asset managers and in cybersecurity. He added: "Post-election about six months ago, there was a lot of enthusiasm about these stocks on the view that higher asset prices and more capital markets activity like IPOs and M & A would boost these stocks. ET each day.)

article thumbnail

Analysts move to the sidelines on CoreWeave stock after big surge since IPO

CNBC: Investing

Its initial public offering earlier this year was the biggest technology IPO since 2021. " Citi analyst Tyler Radke said that the stock could face near-term downside as investors potentially opt to snag Core Scientific stock at a significant markdown. above CoreWeave's Monday close. As such, we view shares as fairly valued."

IPO 67
article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

Portfolio optimization through divestitures of noncore assets In addition to pharmas smaller appetite in 2024, pharma companies continued to slim down by shedding nonessential assets to sharpen their strategic focus on core products.

M&A 64